224.070

-2.220 (-0.98%)

Range 223.170 - 228.424   (2.35%)
Open 227.640
Previous Close 226.290
Buy Price 101.850
Buy Volume -
Sell Price 101.860
Sell Volume -
Volume 1,399,461
Value -
Remark
Measurement Type Value
EPS (USD) 3.463
Trailing EPS (USD) 5.019
NAV (USD) 19.889
Cash In Hand (USD) 5.653
Dividend -
Dividend Yield (%) -
PE 64.711
Trailing PE 44.641
Price / NAV 11.266
Price / Cash In Hand 39.635
Issued & Paid-up Shares 208,570,000
Treasury Shares 9,000,000
Market Cap (M) 46,734.28
Par Value (USD) n.a.
Beta - 75 Days 0.902
R-Squared - 75 Days(%) 13.75
Beta - 500 Days 0.968
R-Squared - 500 Days(%) 18.24
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 26 Feb 2020 05:02.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date: 28 Apr 2020
View All Events

About EDWARDS LIFESCIENCES CORP

Edwards Lifesciences Corporation (Edwards Lifesciences) is focused on technologies that treat structural heart disease and critically ill patients. A pioneer in the development and commercialization of heart valve products, Edwards Lifesciences is the manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. The Company also provides hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The products and technologies provided by Edwards Lifesciences to treat advanced cardiovascular disease or critically ill patients are categorized into three main areas: Surgical Heart Valve Therapy, which combines surgical heart valves and Cardiac Surgery Systems; Transcatheter Heart Valves; and Critical Care, which includes Vascular. In October 2012, it acquired BMEYE B.V.

Loading Chart...


BUY
SELL
Stock
EDWARDS LIFESCIENCES CORP(EW)
Target Price
Add Stop Loss
Time Frames
Editor
Share With: